Company CVAbout Alembic Pharmaceuticals Ltd. 
Alembic Pharmaceuticals Ltd.
Small Cap
Pharmaceuticals & Biotechnology
Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world. The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
Company Coordinates
Company Details
Alembic Road , Vadodara Gujarat : 390003
Registrar Details
Link Intime India Pvt Ltd., B-102 & B103, Shangrila Complex, First Floor, Opp: HDFC Bank, Near Radhakrishna Char Rasta, Akota, Vadodara
Capital StructureCapital Structure
Present Equity Capital
INR 39.31 Cr
Number of Shares
19.66 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
07-Aug-2020
19.66
39.31
8047210
2
Issued to QIBs
20-Sep-2011
18.85
37.70
133515914
2
Scheme of Arrangement
20-Sep-2011
18.85
37.70
133515914
2
Scheme of Arrangement
16-Jun-2010
5.5
11.00
55000000
2
Subscription to the Memorandum of Association
16-Jun-2010
5.5
11.00
55000000
2
Subscription to the Memorandum of Association
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 20 Schemes (8.55%)
FIIs
Held by 150 FIIs (4.05%)
Promoter with highest holding
Nirayu Private Limited (35.65%)
Highest Public shareholder
Dsp Midcap Fund (4.55%)
Individual Investors Holdings
6.93%
Board of Directors
Management
Designation
Remuneration
Chirayu R Amin
Chairman & CEO
8.8 cr
Pranav N Parikh
Independent Director
18.7 lacs
K G Ramanathan
Independent Director
19.1 lacs
Paresh Saraiya
Independent Director
18.7 lacs
Rajkumar Baheti
Director (Finance) & CFO
5.69 cr
Pranav Amin
Managing Director
12.22 cr
Shaunak Amin
Managing Director
12.22 cr
Archana Hingorani
Independent Director
18.3 lacs
Ashok Barat
Independent Director
18.2 lacs
Manisha Saraf
Company Sec. & Compli. Officer
0
Jai S Diwanji
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Goods
3,533.84
96.55%
Export Incentives
88.18
2.41%
Royalty
30.67
0.84%
Pharmaceutical Goods
Pharmaceutical Goods
Export Incentives
Export Incentives
Royalty
Royalty
Stock DNARevenue and Profits:
Net Sales:
1,910 Cr
(Quarterly Results - Sep 2025)
Net Profit:
185 Cr
Pharmaceuticals & Biotechnology
INR 17,691 Cr (Small Cap)
28.00
34
1.22%
0.25
11.93%
3.34
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
